Management of the child with congenital adrenal hyperplasia

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 23, Issue 2, 2009, Pages 193-208

  Hindmarsh, Peter C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

chronic care; circadian rhythm; emergency therapy; fludrocortisone; hydrocortisone; transition

Indexed keywords

AROMATASE INHIBITOR; CORTICOSTEROID; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; HYDROXYPROGESTERONE; INSULIN; MINERALOCORTICOID; PREDNISOLONE; STEROID 21 MONOOXYGENASE;

ADRENAL CORTEX INSUFFICIENCY; BLOOD PRESSURE; BOLUS INJECTION; CHILD; CHILD GROWTH; CONGENITAL ADRENAL HYPERPLASIA; CYSTOSCOPY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; EMERGENCY CARE; ENZYME DEFICIENCY; EVENING DOSAGE; FOLLOW UP; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPERANDROGENISM; HYPERCORTISOLISM; HYPERTENSION; INSULIN RESISTANCE; INTERDISCIPLINARY COMMUNICATION; LOADING DRUG DOSE; LONG TERM CARE; METABOLIC SYNDROME X; MORNING DOSAGE; OBESITY; OSTEOPOROSIS; PATIENT MONITORING; PLASMA RENIN ACTIVITY; PSYCHOLOGICAL ASPECT; PUBERTY; REPRODUCTIVE HEALTH; REVIEW; SIDE EFFECT; SODIUM DEPLETION; SUBSTITUTION THERAPY;

ADRENAL HYPERPLASIA, CONGENITAL; AGING; CHILD; GLUCOCORTICOIDS; HUMANS; LONG-TERM CARE;

EID: 66249104355     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2008.10.010     Document Type: Review

References (52)

1. New M.I., and Wilson R.C. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 12790-12797
2. White P.C., and Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Reviews 21 (2000) 245-291
3. Van Wyk J.J., Gunther D.F., Ritzen E.M., et al. The use of adrenalectomy as a treatment for congenital adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism 81 (1996) 3180-3190
4. Butler D.A., and Lawlor M.T. It takes a village: helping families live with diabetes. Diabetes Spectrum 17 (2004) 26-31
5. Schneider C.E. The practice of autonomy (1998), Oxford University Press, New York
6. Kelley D.L. How to use control charts for healthcare (1999), ASQ Quality Press, Milwaukee
7. Priestland A., and Hanig R. Developing first level leaders. Harvard Business Review 83 (2005) 112-120
8. Lee P.A., Houk C.P., Ahmed S.F., Hughes I.A., and International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 118 (2006) 488-500
9. Krone N., Dhir V., Ivison H.E., et al. Congenital adrenal hyperplasia and P450 oxidoreductase deficiency. Clinical Endocrinology 66 (2007) 162-172
10. Swerdlow A.J., Higgins C., Brook C.G.D., et al. Mortality in patients with congenital adrenal hyperplasia: A cohort study. The Journal of Pediatrics 133 (1998) 516-520
11. Mullis P.E., Hindmarsh P.C., and Brook C.G.D. Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency. European Journal of Pediatrics 150 (1990) 22-25
12. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents (2005), US Department of Heath and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute
13. Minto C.L., Liao L.M., Woodhouse C.R., et al. The effect of clitoral surgery on sexual outcome in individuals who have intersex conditions with ambiguous genitalia: a cross-sectional study. Lancet 12 (2003) 1252-1257
14. Stewart P.M. The adrenal cortex. In: Kronenberg H.M., Melmed S., Polonsky K., et al. (Eds). Williams textbook of endocrinology. 11th edn. (2008), Saunders Elsevier, Philadelphia p. 459
15. Miller W.L. The adrenal cortex and its disorders. In: Brook C.G.D., and Hindmarsh P.C. (Eds). Clinical paediatric endocrinology. 4th edn. (2001), Blackwell Science, Oxford p. 350
16. Charmandari E., Hindmarsh P.C., Johnston A., et al. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 2701-2708
17. Moore J.S., Monson J.P., Kaltsas G., et al. Modulation of 11β-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 4172-4177
18. L'Allemand D., Penhoat A., Lebrethon M.C., et al. Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells. The Journal of Clinical Endocrinology and Metabolism 81 (1996) 3892-3897
19. Moghetti P., Castello R., Negri C., et al. Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. The Journal of Clinical Endocrinology and Metabolism 81 (1996) 881-886
20. Zisper R.D., Speckart P.F., Zia P.K., et al. The effect of ACTH and cortisol on aldosterone and cortisol clearance and distribution in plasma and whole blood. The Journal of Clinical Endocrinology and Metabolism 43 (1976) 1101-1109
21. Singh A., Hamilton-Fairley D., Koistinen R., et al. Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells. The Journal of Endocrinology 124 (1990) R1-R3
22. Smith F.M., Latchford G.J., Hall R.M., et al. Do chronic medical conditions increase the risk of eating disorder? A cross-sectional investigation of eating pathology in adolescent females with scoliosis and diabetes. The Journal of Adolescent Health 42 (2008) 58-63
23. Rivkees S.A., Danon M., and Herrin J. Prednisone dose limitation of growth hormone treatment of steroid-induced growth failure. The Journal of Pediatrics 125 (1994) 322-325
24. Van der Kamp H.J., Otten B.J., Buitenweg N., et al. Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients. Archives of Disease in Childhood 87 (2002) 139-144
25. Bonfig W., Bechtold S., Schmidt H., et al. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty. The Journal of Clinical Endocrinology and Metabolism 92 (2007) 1635-1639
26. Styne D.M., Richards G.E., Bell J.J., et al. Growth patterns in congenital adrenal hyperplasia. Correlation of glucocorticoid therapy with stature. In: Lee P.A., Plotnich L.P., Kowarski A.A., et al. (Eds). Congenital adrenal hyperplasia (1997), University Park Press, Baltimore 247-261
27. Migeon C.J., and Donohue P.A. Congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. Its molecular basis and its remaining therapeutic problems. Endocrinology and Metabolism Clinics of North America 20 (1991) 277-296
28. DiMartino-Nardi J., Stoner E., O'Connell A., et al. The effect of treatment on final height in classical congenital adrenal hyperplasia (CAH). Acta Endocrinologica Supplementum 279 (1986) 305-313
29. Jaaskelainen J., and Voutilainen R. Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height. Pediatric Research 41 (1997) 30-33
30. Manoli I., Kanaka-Gantenbein C., Voutetakis A., et al. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome. Clinical Endocrinology 57 (2002) 669-676
31. Lin-Su K., Vogiatzi M.G., Marshall I., et al. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism 90 (2005) 3318-3325
32. Cornean R.E., Hindmarsh P.C., and Brook C.G.D. Obesity in 21-hydroxylase deficient patients. Archives of Disease in Childhood 78 (1998) 261-263
33. Völkl T.M., Simm D., Beier C., et al. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 117 (2006) e98-105
34. Hague W.M., Adams J., Rodda C., et al. The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clinical Endocrinology 33 (1990) 501-510
35. Stikkelbroeck N.M., Hermus A.R., Schouten D., et al. Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging. European Radiology 14 (2004) 1802-1806
36. Stikkelbroeck N.M., Suliman H.M., Otten B.J., et al. Testicular adrenal rest tumours in postpubertal males with congenital adrenal hyperplasia: sonographic and MR features. European Radiology 13 (2003) 1597-1603
37. Claahsen-van der Grinten H.L., Sweep F.C., Blickman J.G., et al. Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. European Journal of Endocrinology 157 (2007) 339-344
38. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinology and Metabolism Clinics of North America 33 (2004) 283-303
39. Kahn R. Metabolic syndrome-what is the clinical usefulness?. Lancet 371 (2008) 1892-1893
40. Sattar N., McConnachie A., Shaper A.G., et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 371 (2008) 1927-1935
41. Charmandari E., Weise M., Bornstein S.R., et al. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 2114-2120
42. Roche E.F., Charmandari E., Dattani M.T., et al. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report. Clinical Endocrinology 58 (2003) 589-596
43. Merke D.P., Chrousos G.P., Eisenhofer G., et al. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. The New England Journal of Medicine 343 (2000) 1362-1368
44. Doyle L.W., Ford G.W., Davis N.M., et al. Antenatal corticosteroid therapy and blood pressure at 14 years in preterm children. Clinical Science 98 (2000) 127-128
45. Mangos G.J., Turner S.W., Fraser T.B., et al. The role of corticosterone in corticotrophin (ACTH)-induced hypertension in the rat. Journal of Hypertension 18 (2000) 1849-1855
46. Whitworth J.A., Schyvens C.G., Zhang Y., et al. Glucocorticoid-induced hypertension: from mouse to man. Clinical and Experimental Pharmacology and Physiology 28 (2001) 993-996
47. Tunstall-Pedoe H. Myth and paradox of coronary risk and the menopause. Lancet 351 (1998) 1425-1427
48. Gussinyé M., Carrascosa A., Potau N., et al. Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia. Pediatrics 100 (1997) 671-674
49. Paganini C., Radetti G., Livieri C., et al. Height, bone mineral density and bone markers in congenital adrenal hyperplasia. Hormone Research 54 (2000) 164-168
50. Department of Health. Transition: getting it right for young people: improving the transition of young people with long term conditions from children's to adult health services. Available from: (2006). http://www.dh.gov.uk/PublicationsAndStatistics/Publications/Publications PolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/
51. Datta J. Moving up with diabetes: the transition from paediatric to adult care. National Children's Bureau (2003)
52. Dovey-Pearce G., Hurrell R., and Doherty Y. Young adults' (16-25 years) suggestions for providing developmentally appropriate diabetes services: a qualitative study. Health and Social Care in the Community 13 (2005) 409-419